Dan Gilbert Donates $50M Yearly to Cure Son's Disease

When Cleveland Cavaliers owner Dan Gilbert lost his son Nick to neurofibromatosis in 2023, he turned his heartbreak into hope for millions of families facing the same battle.

Gilbert, 64, now contributes $50 million annually through his Gilbert Family Foundation to find a cure for the rare genetic disorder that claimed Nick's life at just 26 years old. "He was my hero," Gilbert told CNBC this week. "In his legacy and his honor, we're trying our hardest to wipe this disease off the planet."

Nick was diagnosed with neurofibromatosis (NF1) as a toddler when a tumor appeared on his optic nerve. The genetic disorder causes tumors to grow on nerve tissue throughout the body, including the brain and spinal cord, and has no cure.

For years, Nick's tumor remained stable. But around age six, it started growing, leading to his first major surgery at age 10 and years of chemotherapy and radiation treatments.

Basketball fans knew Nick as the young man who often stood beside his father at NBA events, including the unforgettable 2011 and 2013 draft lotteries where the Cavaliers won the number one pick. Behind the scenes, he was fighting a relentless disease.

The final years of Nick's life brought aggressive tumors, including one on his brainstem that affected his ability to breathe, see, hear, and communicate. He died on May 6, 2023, surrounded by family who promised to continue his fight.

Why This Inspires

The Gilbert family has transformed their loss into lasting change. They opened Gilly's Clubhouse in downtown Detroit, named after Nick's nickname among friends. His siblings launched The Gilly Project, a community nonprofit carrying forward his spirit.

Gilbert himself refocused the foundation he started with his ex-wife Jennifer in 2015, making neurofibromatosis research its primary mission. After surviving a major stroke in 2019 and losing Nick four years later, he's learned to channel his energy into what he can control.

"You just have to get the next card and try to play it," Gilbert explained. "You work on the things you try to control."

His $50 million annual commitment represents one of the largest private investments in NF1 research, bringing renewed energy to scientists working toward treatments and ultimately a cure.

Nick's legacy now reaches far beyond basketball, touching families worldwide who face neurofibromatosis diagnoses with more hope than ever before.